Please login to the form below

Not currently logged in

EFPIA appoints Hubertus von Baumbach as president

Von Baumbach will serve as president of the EFPIA for the next two years

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed Hubertus von Baumbach (pictured above) as president for the next two years.

Von Baumbach currently serves as chairman of the board of managing directors at Boehringer Ingelheim, a role he was appointed to in 2016.

Baumbach had been a member of Boehringer’s board of managing directors since 2009, and he has also previously worked at Roche in the US and for Boehringer in Canada.

Commenting on his appointment as president of the EFPIA, von Baumbach said: “The pandemic has severely tested European health and economic resilience. But COVID-19 has also underlined the critical importance of a strong and competitive research, development and medical innovation ecosystem to address major health challenges and drive economic growth.

He added: “Over the coming months, my colleagues and I look forward to engaging with the EU Institutions and across Member States to discuss how we can work together to ensure that the EU remains an innovation leader and to build a healthier future for European citizens.”

Article by
Lucy Parsons

22nd June 2021

From: Marketing


Subscribe to our email news alerts

Featured jobs


Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Environment: where does the pharmaceutical industry stand?
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...